David M. Epstein - 04 Jun 2025 Form 4 Insider Report for GYRE THERAPEUTICS, INC. (GYRE)

Role
Director
Signature
/s/ Ruoyu Chen, as attorney-in-fact for David M. Epstein
Issuer symbol
GYRE
Transactions as of
04 Jun 2025
Transactions value $
$0
Form type
4
Filing time
06 Jun 2025, 16:22:42 UTC
Previous filing
16 Aug 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Epstein David M. Director C/O GYRE THERAPEUTICS, INC., 12770 HIGH BLUFF DRIVE, SUITE 150, SAN DIEGO /s/ Ruoyu Chen, as attorney-in-fact for David M. Epstein 06 Jun 2025 0001488668

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GYRE Stock Option (Right to Buy) Award $0 +26K $0.00 26K 04 Jun 2025 Common Stock 26K $8.58 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase a total of 26,000 shares of the Issuer's common stock, which will vest in 12 equal monthly installments through June 4, 2026, subject to the Reporting Person's continued service to the Issuer through each vesting date.